References
Holder GE. The pattern electroretinogram. In: Fishman GA, Birch DG, Holder GE, Brigell MG. Electrophysiologic Testing in Disorders of the Retina, Optic Nerve, and Visual Pathway, Second Edition. Ophthalmology Monograph 2. San Francisco: The Foundation of the American Academy of Ophthalmology; 2001: 197–235.
Bach M, Hawlina M, Holder GE, Marmor MF, Meigen T, Vaegan, Miyake Y. Standard for pattern electroretinography. Doc Ophthalmol 2000; 101: 11–18.
Holder GE. The significance of abnormal pattern electroretinography in anterior visual pathway dysfunction. Br J Ophthalmol 1987; 71: 166–71.
Viswanathan S, Frishman LJ, Robson JG. The uniform field and pattern ERG in macaques with experimental glaucoma: removal of spiking activity. Invest Ophthalmol Vis Sci 2000; 41: 2797–810.
Holder GE. The pattern electroretinogram and an integrated approach to visual pathway diagnosis. Prog Retin Eye Res 2001; 20: 531–61.
Groneberg A. Simultaneously recorded retinal and cortical potentials elicited by checkerboard stimuli. Doc Ophthalmol Proc Ser 1980; 23: 255–62.
Arden GB, Vaegan, Hogg CR. Clinical and experimental evidence that the pattern electroretinogram (PERG) is generated in more proximal retinal layers than the focal electroretinogram (FERG). Ann NY Acad Sci 1982; 388: 214–26.
Celesia GG, Kaufman D. Pattern ERGs and visual evoked potentials in maculopathies and optic nerve diseases. Invest Ophthalmol Vis Sci 1985; 26: 726–35.
Ryan S, Arden GB. Electrophysiological discrimination between retinal and optic nerve disorders. Doc Ophthalmol 1988; 68: 247–55.
Clarke MP, Mitchell KW, McDonnell S. Electroretinographic findings in macular dystrophy. Doc Ophthalmol 1997; 92:325–39.
Holder GE. The pattern electroretinogram in anterior visual pathway dysfunction and its relationship to the pattern visual evoked potential: A personal clinical review of 743 eyes. Eye 1997; 11: 924–34.
Holder GE. The incidence of abnormal pattern electroretinography in optic nerve demyelination. Electroencephalogr Clin Neurophysiol 1991; 78: 18–26.
Berninger TA, Jaeger W, Krastel H. Electrophysiology and colour perimetry in dominant infantile optic atrophy. Br J Ophthalmol 1991; 75: 49–52.
Votruba M, Fitzke FW, Holder GE, Carter A, Bhattacharya SS, Moore AT. Clinical features in affected individuals from 21 pedigrees with Dominant Optic Atrophy. Arch Ophthalmol 1998; 116: 351–8.
von Ruckmann A, Fitzke FW, Bird AC. In vivo fundus auto-fluorescence in macular dystrophies. Arch Ophthalmol 1997; 115: 609–15.
Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Weiter JJ. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelial lipofuscin characteristics. Invest Ophthalmol Vis Sci 1995; 36: 718–29.
Marmor MF, Zrenner E. Standard for Clinical Electroretinography (1998 update). Doc Ophthalmol 1999; 89: 199–210.
Allikmets R, Singh N, Sun H, Shroyer NF, Hutchinson A, Chidambaram A, Gerrard B, Baird L, Stauffer D, Peiffer A, Rattner A, Smallwood P, Li Y, Anderson KL, Lewis RA, Nathans J, Leppert M, Dean M, Lupski JR. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nature Genet 1997; 15: 236–45.
Sun H, Nathans J. Stargardt's ABCR is localised to the disc membrane of retinal outer segments. Nat Genet 1997; 17: 15–6.
Molday LL, Rabin AR, Molday RS. ABCR expression in foveal cone photoreceptors and its role in Stargardt macular dystrophy. Nat Genet 2000; 25: 257–8.
Weng J, Mata NL, Azarian SM, Tzekov RT, Birch DG, Travis GH. Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice. Cell 1999; 98: 13–23.
Lois N, Holder GE, Fitzke FW, Plant C, Bird AC. Intrafamilial variation of phenotype in Stargardt macular dystrophy – fundus flavimaculatus. Invest Ophthalmol Vis Sci 1999; 40: 2668–75.
Lois N, Holder GE, Bunce C, Fitzke FW, Bird AC. Stargardt macular dystrophy – fundus flavimaculatus: phenotypic subtypes. Arch Ophthalmol 2001; 119: 359–69.
Kurz-Levin M, Halfyard AS, Bunce C, Bird AC, Holder GE. Clinical variations in assessment of Bull's Eye Maculopathy. Arch Ophthalmol 2002; 120: 567–75.
Robson AG, El-Amir A, Bailey C, Egan C, Bird AC, Fitzke FW, Holder GE. The use of the pattern ERG and fundus auto-fluorescence in the assessment of patients with generalised photoreceptor dystrophy and preserved central vision. Invest Ophthalmol Vis Sci. 2001; 42: S72 (ARVO abstract).
Corbett MC, Shilling JS, Holder GE. The assessment of clinical investigations: the Greenwich grading system and its application to electrodiagnostic testing in ophthalmology. Eye 1995; 9 (Suppl): 59–64.
Sutter EE, Tran D. The field topography of ERG components in man. I. The photopic luminance response. Vision Res 1992; 32: 433–46.
Hood DC. Assessing retinal function with the multifocal technique. Prog Retin Eye Res 2000; 19: 607–46.
Kretschmann U, Bock M, Gockeln R, Zrenner E. Clinical applications of multifocal electroretinography. Doc Ophthalmol 2000; 100: 99–113.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holder, G., Robson, A., Hogg, C. et al. Pattern ERG: clinical overview, and some observations on associated fundus autofluorescence imaging in inherited maculopathy. Doc Ophthalmol 106, 17–23 (2003). https://doi.org/10.1023/A:1022471623467
Issue Date:
DOI: https://doi.org/10.1023/A:1022471623467